View in EDS

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer.

Saved in:
Bibliographic Details
Title: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer.
Authors: Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany. rammensee@uni-tuebingen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany. rammensee@uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany. rammensee@uni-tuebingen.de., Wiesmüller KH; EMC microcollections GmbH, Tübingen, Germany., Chandran PA; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Zelba H; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Rusch E; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Gouttefangeas C; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany., Kowalewski DJ; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany., Di Marco M; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Haen SP; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany., Walz JS; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany., Gloria YC; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Bödder J; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Schertel JM; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany., Tunger A; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Müller L; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany., Kießler M; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany., Wehner R; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Schmitz M; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Jakobi M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Schneiderhan-Marra N; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Klein R; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany., Laske K; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Artzner K; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Backert L; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany., Schuster H; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany., Schwenck J; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital of Tübingen, Tübingen, Germany.; Werner Siemens Imaging Center, Medical Faculty, University of Tübingen, Tübingen, Germany., Weber ANR; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany., Pichler BJ; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Werner Siemens Imaging Center, Medical Faculty, University of Tübingen, Tübingen, Germany., Kneilling M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Werner Siemens Imaging Center, Medical Faculty, University of Tübingen, Tübingen, Germany.; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., la Fougère C; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital of Tübingen, Tübingen, Germany., Forchhammer S; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Metzler G; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Bauer J; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Weide B; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Schippert W; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Stevanović S; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany., Löffler MW; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany. markus.loeffler@med.uni-tuebingen.de.; Department of General, Visceral and Transplant Surgery, University Hospital of Tübingen, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.; Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Nov 15; Vol. 7 (1), pp. 307. Date of Electronic Publication: 2019 Nov 15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31730025
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rammensee+HG%22">Rammensee HG</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany. rammensee@uni-tuebingen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany. rammensee@uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany. rammensee@uni-tuebingen.de.<br /><searchLink fieldCode="AU" term="%22Wiesmüller+KH%22">Wiesmüller KH</searchLink>; EMC microcollections GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Chandran+PA%22">Chandran PA</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Zelba+H%22">Zelba H</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rusch+E%22">Rusch E</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Gouttefangeas+C%22">Gouttefangeas C</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kowalewski+DJ%22">Kowalewski DJ</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Di+Marco+M%22">Di Marco M</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Haen+SP%22">Haen SP</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Walz+JS%22">Walz JS</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Gloria+YC%22">Gloria YC</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bödder+J%22">Bödder J</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schertel+JM%22">Schertel JM</searchLink>; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Tunger+A%22">Tunger A</searchLink>; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+L%22">Müller L</searchLink>; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Kießler+M%22">Kießler M</searchLink>; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Wehner+R%22">Wehner R</searchLink>; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitz+M%22">Schmitz M</searchLink>; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jakobi+M%22">Jakobi M</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schneiderhan-Marra+N%22">Schneiderhan-Marra N</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Klein+R%22">Klein R</searchLink>; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Laske+K%22">Laske K</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Artzner+K%22">Artzner K</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Backert+L%22">Backert L</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schuster+H%22">Schuster H</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schwenck+J%22">Schwenck J</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital of Tübingen, Tübingen, Germany.; Werner Siemens Imaging Center, Medical Faculty, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Weber+ANR%22">Weber ANR</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.<br /><searchLink fieldCode="AU" term="%22Pichler+BJ%22">Pichler BJ</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Werner Siemens Imaging Center, Medical Faculty, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kneilling+M%22">Kneilling M</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Werner Siemens Imaging Center, Medical Faculty, University of Tübingen, Tübingen, Germany.; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22la+Fougère+C%22">la Fougère C</searchLink>; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Forchhammer+S%22">Forchhammer S</searchLink>; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Metzler+G%22">Metzler G</searchLink>; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bauer+J%22">Bauer J</searchLink>; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Weide+B%22">Weide B</searchLink>; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schippert+W%22">Schippert W</searchLink>; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Stevanović+S%22">Stevanović S</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.<br /><searchLink fieldCode="AU" term="%22Löffler+MW%22">Löffler MW</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany. markus.loeffler@med.uni-tuebingen.de.; Department of General, Visceral and Transplant Surgery, University Hospital of Tübingen, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.; Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2019 Nov 15; Vol. 7 (1), pp. 307. <i>Date of Electronic Publication: </i>2019 Nov 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31730025
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s40425-019-0796-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 307
    Titles:
      – TitleFull: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rammensee HG
      – PersonEntity:
          Name:
            NameFull: Wiesmüller KH
      – PersonEntity:
          Name:
            NameFull: Chandran PA
      – PersonEntity:
          Name:
            NameFull: Zelba H
      – PersonEntity:
          Name:
            NameFull: Rusch E
      – PersonEntity:
          Name:
            NameFull: Gouttefangeas C
      – PersonEntity:
          Name:
            NameFull: Kowalewski DJ
      – PersonEntity:
          Name:
            NameFull: Di Marco M
      – PersonEntity:
          Name:
            NameFull: Haen SP
      – PersonEntity:
          Name:
            NameFull: Walz JS
      – PersonEntity:
          Name:
            NameFull: Gloria YC
      – PersonEntity:
          Name:
            NameFull: Bödder J
      – PersonEntity:
          Name:
            NameFull: Schertel JM
      – PersonEntity:
          Name:
            NameFull: Tunger A
      – PersonEntity:
          Name:
            NameFull: Müller L
      – PersonEntity:
          Name:
            NameFull: Kießler M
      – PersonEntity:
          Name:
            NameFull: Wehner R
      – PersonEntity:
          Name:
            NameFull: Schmitz M
      – PersonEntity:
          Name:
            NameFull: Jakobi M
      – PersonEntity:
          Name:
            NameFull: Schneiderhan-Marra N
      – PersonEntity:
          Name:
            NameFull: Klein R
      – PersonEntity:
          Name:
            NameFull: Laske K
      – PersonEntity:
          Name:
            NameFull: Artzner K
      – PersonEntity:
          Name:
            NameFull: Backert L
      – PersonEntity:
          Name:
            NameFull: Schuster H
      – PersonEntity:
          Name:
            NameFull: Schwenck J
      – PersonEntity:
          Name:
            NameFull: Weber ANR
      – PersonEntity:
          Name:
            NameFull: Pichler BJ
      – PersonEntity:
          Name:
            NameFull: Kneilling M
      – PersonEntity:
          Name:
            NameFull: la Fougère C
      – PersonEntity:
          Name:
            NameFull: Forchhammer S
      – PersonEntity:
          Name:
            NameFull: Metzler G
      – PersonEntity:
          Name:
            NameFull: Bauer J
      – PersonEntity:
          Name:
            NameFull: Weide B
      – PersonEntity:
          Name:
            NameFull: Schippert W
      – PersonEntity:
          Name:
            NameFull: Stevanović S
      – PersonEntity:
          Name:
            NameFull: Löffler MW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 11
              Text: 2019 Nov 15
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1